Yesterday, shares of Valeant Pharmaceuticals International plunged as much as 20%.
Yesterday, shares of Valeant Pharmaceuticals International plunged as much as 20%, building on weeks of losses, reports Reuters.
Reuters adds that these previous losses were mainly due to “concerns about [Valeant’s] ties to specialty pharmacy Philidor Rx Services and its sharp drug price increases,” and those ties have since been cut. Read more.
The proportion of women CEOs in the CSA's sample remains 5%, as in the past three annual reports
BMO tops equity league tables, RBC leads debt rankings
Industry watchdogs can't "sit in an ivory tower" as they push for industry change, said Stan Magidson
Clients satisfied with advisors, despite fewer fee and suitability discussions
Help clients get the maximum benefit from these accounts
Laurentian Bank has announced further executive shifts following its leadership change earlier this month
Ontario court allows U.S. shareholders to pursue both cases
Report finds the technology is being used to segment clients and generate insights